Incidence trends of different cancers attributable to smoking and alcohol consumption in Liaoning Province, Northeastern China from 2008 to 2019
To analyze the trends in cancer burden attributable to smoking and alcohol consumption in Liaoning Province from 2008 to 2019. Data on smoking and alcohol consumption were obtained from the Liaoning Provincial Chronic Disease and Behavioral Risk Factor Surveillance. Cancer incidence data were sourced from the Liaoning Province Cancer Registry Reporting System. We calculated the population attributable fraction (PAF) and age-standardized incidence rate (ASIR) for cancers attributable to smoking, alcohol consumption, and the combined effects of both. In 2019, the PAFm attributable to smoking, alcohol consumption, and their combination in males in Liaoning Province were 38.68% (95% CI 25.37–50.22), 10.91% (95% CI 3.87–19.31), and 32.81% (95% CI 20.73–43.37), respectively, while the corresponding values in females were 8.73% (95% CI 3.03–17.99), 0.68% (95% CI 0.10–2.02), and 8.87% (95% CI 3.03–18.42), respectively. Among cancers attributable to smoking, lung cancer had the highest PAFm in both males and females. Among cancers attributable to alcohol consumption, oropharyngeal cancer had the highest PAFm. The ASIRs attributable to smoking, alcohol consumption, and their combination in males were 99.14 per 100,000 (95% CI 64.87-128.86), 14.95 per 100,000 (95% CI 5.32–26.48), and 110.45 per 100,000 (95% CI 69.33-147.05), respectively, while the values in females were 14.06 per 100,000 (95% CI 4.74–29.56), 0.42 per 100,000 (95% CI 0.06–1.24), and 14.46 per 100,000 (95% CI 4.80–30.70), respectively. Lung cancer had the highest ASIR among cancers attributable to smoking in both genders, while colorectal cancer had the highest ASIR among cancers attributable to alcohol consumption in both genders. The cancer burden attributable to smoking and alcohol consumption remains high. Future health policy formulation needs to consider these factors more comprehensively and implement targeted interventions.
Authors
- H.B. Li
- Huijuan Mu
- Guowei Pan
- Ruixue Yue (ORCID: https://orcid.org/0000-0003-1400-5753)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-6488-0591)
- Chen Li (ORCID: https://orcid.org/0000-0002-7513-0411)
- Li Liu (ORCID: https://orcid.org/0000-0002-9427-930X)
- Hongfeng Li (ORCID: https://orcid.org/0000-0003-1882-6145)
- Wenzheng Sun (ORCID: https://orcid.org/0000-0003-2629-744X)
- Yanxia Li (ORCID: https://orcid.org/0000-0002-9921-2454)
- Yuehua Wang (ORCID: https://orcid.org/0000-0001-6845-930X)
- Jingying Li (ORCID: https://orcid.org/0000-0002-8847-5339)
- Qian Ren (ORCID: https://orcid.org/0000-0001-7731-7936)
Institutions
- Shenyang Medical College (CN)
- General Electric (Spain) (ES)
- Shenyang Center for Disease Control and Prevention (CN)
- Ministry of Education (PT)
- First Hospital of China Medical University (CN)
- Shenyang University (CN)
- China Medical University (CN)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1186/s12889-025-24289-5
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00